Lv1
40 积分 2025-12-23 加入
Recaticimab: The First Fc-Engineered PCSK9 Monoclonal Antibody for More Long-Lasting Effect in Lipid Lowering
1个月前
已完结
The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic
4个月前
已完结
Unravelling cysteine-deficiency-associated rapid weight loss
6个月前
已完结
Long-acting MIC-1/GDF15 molecules to treat obesity: Evidence from mice to monkeys
7个月前
已完结
Novel Dual and Triple Agonists Targeting GLP-1, GIP, Glucagon, and GDF15 for Type 2 Diabetes and Obesity Management
7个月前
已完结
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
7个月前
已完结
AI-driven protein design
7个月前
已完结
The mitochondrial integrated stress response: A novel approach to anti-aging and pro-longevity
7个月前
已完结
The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic
7个月前
已完结
GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates
7个月前
已完结
皖公网安备34019202002308
